Top-News

Nordic Nanovector News

Aktie
WKN:  A1H64K ISIN:  NO0010597883
0,0648 €
-0,0137 €
-17,45%
06.05.24 17:01:00
Handeln Depot/Watchlist
Aktienanzahl *
98,08 Mio.
Marktkapitalisierung *
9,37 Mio. €
Streubesitz
-
Index-Zugehörigkeit
-
IR-Website
zur Website
*Stand: 08.11.2021

Nordic Nanovector News

01.07.21 - PR Newswire
Nordic Nanovector Appoints Malene Brondberg as Interim Chief Executive Officer
Nordic Nanovector Appoints Malene Brondberg as Interim Chief Executive Officer PR Newswire
01.07.21 - PR Newswire
Nordic Nanovector Appoints Malene Brondberg as Interim Chief Executive Officer
Nordic Nanovector Appoints Malene Brondberg as Interim Chief Executive Officer PR Newswire
22.06.21 - PR Newswire
Nordic Nanovector ASA: Share capital increase registered
Nordic Nanovector ASA: Share capital increase registered PR Newswire
22.06.21 - PR Newswire
Nordic Nanovector ASA: Share capital increase registered
Nordic Nanovector ASA: Share capital increase registered PR Newswire
22.06.21 - PR Newswire
Nordic Nanovector Announces Initial Results from LYMRIT 37-05 Phase 1 Trial of Betalutin® in Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL)
Nordic Nanovector Announces Initial Results from LYMRIT 37-05 Phase 1 Trial of Betalutin® in Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL) PR Newswire
22.06.21 - PR Newswire
Nordic Nanovector Announces Initial Results from LYMRIT 37-05 Phase 1 Trial of Betalutin® in Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL)
Nordic Nanovector Announces Initial Results from LYMRIT 37-05 Phase 1 Trial of Betalutin® in Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL) PR Newswire
18.06.21 - PR Newswire
Nordic Nanovector ASA: Allocation of restricted stock units (RSUs) to the board of directors
Nordic Nanovector ASA: Allocation of restricted stock units (RSUs) to the board of directors PR Newswire
18.06.21 - PR Newswire
Nordic Nanovector ASA: Allocation of restricted stock units (RSUs) to the board of directors
Nordic Nanovector ASA: Allocation of restricted stock units (RSUs) to the board of directors PR Newswire
18.06.21 - PR Newswire
Nordic Nanovector ASA: Increase of share capital
Nordic Nanovector ASA: Increase of share capital PR Newswire
18.06.21 - PR Newswire
Nordic Nanovector ASA: Increase of share capital
Nordic Nanovector ASA: Increase of share capital PR Newswire
18.06.21 - PR Newswire
Nordic Nanovector ASA: Increase of share capital
Nordic Nanovector ASA: Increase of share capital PR Newswire
18.06.21 - PR Newswire
Nordic Nanovector ASA: Increase of share capital
Nordic Nanovector ASA: Increase of share capital PR Newswire
02.06.21 - PR Newswire
Nordic Nanovector ASA: Allocation of restricted stock units (RSUs) to the board of directors
Nordic Nanovector ASA: Allocation of restricted stock units (RSUs) to the board of directors PR Newswire
02.06.21 - PR Newswire
Nordic Nanovector ASA: Allocation of restricted stock units (RSUs) to the board of directors
Nordic Nanovector ASA: Allocation of restricted stock units (RSUs) to the board of directors PR Newswire
26.05.21 - PR Newswire
Nordic Nanovector ASA: Results for the First Quarter 2021
Nordic Nanovector ASA: Results for the First Quarter 2021 PR Newswire
26.05.21 - PR Newswire
Nordic Nanovector ASA: Results for the First Quarter 2021
Nordic Nanovector ASA: Results for the First Quarter 2021 PR Newswire
25.05.21 - PR Newswire
Nordic Nanovector Announces Update from Archer-1 Phase 1b Trial of Betalutin® in combination with rituximab in 2L Follicular Lymphoma
Nordic Nanovector Announces Update from Archer-1 Phase 1b Trial of Betalutin® in combination with rituximab in 2L Follicular Lymphoma PR Newswire
25.05.21 - PR Newswire
Nordic Nanovector Announces Update from Archer-1 Phase 1b Trial of Betalutin® in combination with rituximab in 2L Follicular Lymphoma
Nordic Nanovector Announces Update from Archer-1 Phase 1b Trial of Betalutin® in combination with rituximab in 2L Follicular Lymphoma PR Newswire
20.05.21 - PR Newswire
Nordic Nanovector ASA: Invitation to First Quarter 2021 Results Presentation and Webcast
Nordic Nanovector ASA: Invitation to First Quarter 2021 Results Presentation and Webcast PR Newswire
20.05.21 - PR Newswire
Nordic Nanovector ASA: Invitation to First Quarter 2021 Results Presentation and Webcast
Nordic Nanovector ASA: Invitation to First Quarter 2021 Results Presentation and Webcast PR Newswire

Newssuche

Videos

newspaper
06.05.24 +6,89%
Technical Trading: Rohöl Short Chance
Rohöl Short Typ: Turbo Open End WKN: VD4JF9 Hebel: 13 Laufzeit: OpenEnd Einstieg: Market ... Mehr »